Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALFIWNYSE:BTXNASDAQ:CIDMNASDAQ:NLOK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALFIWAlfi$0.00$0.00▼$2.88N/AN/A6,051 shsN/ABTXBrooklyn ImmunoTherapeutics$6.48+0.8%$2.25$6.35▼$8.31$381.19M4.61836,949 shs641,277 shsCIDMCinedigm$3.49-4.1%$1.54$0.27▼$0.79$652.33M2.05710,288 shs110,410 shsNLOKNortonLifeLock$27.05-2.3%$27.45$20.12▼$30.92$15.46B0.765.78 million shs5.49 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALFIWAlfi0.00%0.00%0.00%0.00%-99.49%BTXBrooklyn ImmunoTherapeutics+0.31%-6.96%+1,811.85%+1,882.09%+159.92%CIDMCinedigm+0.83%+4.60%-7.85%-0.55%+184.38%NLOKNortonLifeLock-1.84%+0.18%+0.22%-7.14%+25.46%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALFIWAlfiN/AN/AN/AN/AN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACIDMCinedigmN/AN/AN/AN/AN/AN/AN/AN/ANLOKNortonLifeLock1.3509 of 5 stars0.00.01.73.61.81.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALFIWAlfi 0.00N/AN/AN/ABTXBrooklyn ImmunoTherapeutics 0.00N/AN/AN/ACIDMCinedigm 0.00N/AN/AN/ANLOKNortonLifeLock 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALFIWAlfi$200.68KN/AN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeutics$-61.58M-6.19N/AN/AN/A∞CIDMCinedigm$72.33M9.02N/AN/AN/A∞NLOKNortonLifeLock$2.82B5.49N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALFIWAlfiN/AN/A0.00N/AN/AN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeuticsN/A-$2.27N/A∞N/AN/AN/AN/AN/ACIDMCinedigmN/A-$0.05N/A∞N/AN/AN/AN/AN/ANLOKNortonLifeLockN/A$1.4318.92∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALFIWAlfiN/AN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeutics$0.9114.04%N/AN/A N/ACIDMCinedigmN/AN/AN/AN/AN/ANLOKNortonLifeLock$0.501.85%+44.22%34.97%N/ALatest CIDM, BTX, ALFIW, and NLOK DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/3/2025BTXBrooklyn ImmunoTherapeuticsMonthly$0.08623/14/20253/14/20253/31/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALFIWAlfiN/ABTXBrooklyn ImmunoTherapeutics26.00%CIDMCinedigm8.03%NLOKNortonLifeLock94.86%Insider OwnershipCompanyInsider OwnershipALFIWAlfiN/ABTXBrooklyn ImmunoTherapeutics20.50%CIDMCinedigm16.40%NLOKNortonLifeLock3.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALFIWAlfi40N/AN/ANot OptionableBTXBrooklyn ImmunoTherapeuticsN/A58.83 millionN/ANo DataCIDMCinedigm140186.92 millionN/ANot OptionableNLOKNortonLifeLockN/A571.37 millionN/ANo DataCIDM, BTX, ALFIW, and NLOK HeadlinesRecent News About These CompaniesNortonLifeLock (NASDAQ:NLOK) Coverage Initiated by Analysts at StockNews.comMarch 7, 2025 | americanbankingnews.comNortonLifeLock (NASDAQ:NLOK) Now Covered by StockNews.comMarch 5, 2025 | marketbeat.comStockNews.com Initiates Coverage on NortonLifeLock (NASDAQ:NLOK)February 25, 2025 | marketbeat.comNortonLifeLock (NASDAQ:NLOK) Now Covered by Analysts at StockNews.comFebruary 17, 2025 | marketbeat.comGen Digital Inc. (NLOK.VI)August 30, 2024 | finance.yahoo.comGen Digital Inc 1NLOKJuly 25, 2024 | morningstar.comGen Digital (GEN) Earnings Dates & ReportsAugust 4, 2023 | investing.comTime to question our dividend-based stock screenAugust 1, 2023 | investorschronicle.co.ukGen Digital (NASDAQ: GEN)July 8, 2023 | fool.comGen Digital (GEN) Beats on Q4 Earnings and Revenue EstimatesMay 12, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCIDM, BTX, ALFIW, and NLOK Company DescriptionsAlfi NASDAQ:ALFIWAlfi, Inc. provides interactive intelligent artificial intelligence and machine learning software solutions. Alfi, Inc. was formerly known as Lectrefy, Inc. and changed its name to Alfi, Inc. in January 2020. The company was founded in 2018 and is based in Miami Beach, Florida.Brooklyn ImmunoTherapeutics NYSE:BTX$6.48 +0.05 (+0.78%) As of 03:58 PM EasternEterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.Cinedigm NASDAQ:CIDMCineverse Corp. is a global streaming technology and entertainment company. It owns and operates streaming channels, all powered by its advanced, proprietary technology platform. The firm currently features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. It entertains consumers around the globe by providing premium feature films and television series, enthusiast streaming channels, and technology services to some media, retail, and technology companies. The company was founded by A. Dale Mayo on March 31, 2000 and is headquartered in New York, NY.NortonLifeLock NASDAQ:NLOK$27.05 -0.64 (-2.31%) As of 03/11/2025Gen Digital, Inc. engages in the provision of security, storage, and systems management solutions. The firm focuses on providing consumer cyber safety with its business solutions. The company was founded by Gary Hendrix in April 1982 and is headquartered in Tempe, AZ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ramaco Resources Pins Hopes on Coal's Untapped Potential Beyond a Market Correction, Moves to Make Now NVIDIA Stock Remains Stunningly Undervalued—Here’s Why Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy 3 Stocks Institutions Are Quietly Dumping Marvell’s 40% Drop Presents a Compelling Buying Opportunity These 3 Dividend Stocks Jumped 15% in a Month—More to Come? Why Wayfair Stock May Be a Hidden Gem for Value Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
